Health Condition 1: C439- Malignant melanoma of skin, unspecified Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C759- Malignant neoplasm of endocrine gland, unspecified Health Condition 4: C579- Malignant neoplasm of female genital organ, unspecified Health Condition 5: C269- Malignant neoplasm of ill-definedsites within the digestive system Health Condition 6: C639- Malignant neoplasm of male genitalorgan, unspecified Health Condition 7: C409- Ma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients belonging to ASA physical status 1 and 2 patients consenting for study
Exclusion criteria
Exclusion criteria: patient refusal patients belonging to ASA physical status 3 or more. any contraindication for the study drugs diltiazem, esmolol, lignocaine. pregnant and lactating woman. patients posted for emergency surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemodynamic stress response to endotracheal extubationTimepoint: 2minutes before and at 0,1,2,3,5,10 minutes after endotracheal extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| complications like hypotension and bradycardia associated with the drug. airway reflexes like cough, laryngospasm, bronchospasm.Timepoint: 2minutes before and at 0,1,2,3,5,10 minutes after endotracheal extubation | — |
Countries
India
Contacts
kidwai memorial institute of oncology